Literature DB >> 34961886

The deleterious impact of a non-synonymous SNP on protein structure and function is apparent in hypertension.

Kavita Sharma1,2, Kanipakam Hema1, Naveen Kumar Bhatraju1, Ritushree Kukreti1, Rajat Subhra Das3,4, Mohit Dayal Gupta5, Mansoor Ali Syed6, M A Qadar Pasha7.   

Abstract

Essential hypertension (EH) is a significant health issue around the globe. The indifferent therapy regimen suggests varied physiological functions due to the lifestyle and genetic presentations of an individual. The endothelial nitric oxide synthase (NOS3) gene is a crucial vascular system marker in EH that contributes significantly to the phenotype. Hence, the present study aimed to employ the candidate gene approach and investigate the association between NOS3 single nucleotide polymorphism (SNP) E298D (G894T/rs1799983) by applying several in silico tools and validation through human samples screening. We corroborated computational findings through a case-control study comprising 294 controls and 299 patients; the 894T allele emerged significantly as the risk allele (odds ratio=2.07; P=6.38E-05). The in silico analyses highlighted the significance of E298D on the native structure and function of NOS3. The dynamics simulation study revealed that the variant type 298D caused structural destabilization of the protein to alter its function. Plasma nitrite levels were reduced in patients (P=0.0002), and the same correlated with the 894T allele. Furthermore, correlations were apparent between clinical, genotype, and routine biochemical parameters. To conclude, the study demonstrated a perceptible association between the SNP E298D and NOS3 protein structure stability that appears to have a bearing on the enzyme's function with a deleterious role in EH.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Essential hypertension; Genotyping; Missense SNP; Molecular docking simulations; NOS3

Mesh:

Substances:

Year:  2021        PMID: 34961886     DOI: 10.1007/s00894-021-04997-6

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  31 in total

Review 1.  Essential hypertension. Part I: definition and etiology.

Authors:  O A Carretero; S Oparil
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

2.  Control of hypertension--an important national priority.

Authors:  A V Chobanian
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

3.  The epistasis between vascular homeostasis genes is apparent in essential hypertension.

Authors:  Rahul Kumar; Azim Nejatizadeh; Mohit Gupta; Amandeep Markan; Sanjay Tyagi; S K Jain; M A Qadar Pasha
Journal:  Atherosclerosis       Date:  2011-11-02       Impact factor: 5.162

4.  eNOS allelic variants at the same locus associate with HAPE and adaptation.

Authors:  A Ahsan; R Charu; M A Q Pasha; T Norboo; R Charu; F Afrin; A Ahsan; M A Baig
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema.

Authors:  Aarif Ahsan; Ghulam Mohd; Tsering Norboo; Masroor A Baig; M A Qadar Pasha
Journal:  Chest       Date:  2006-11       Impact factor: 9.410

7.  A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK.

Authors:  A D Hingorani; C F Liang; J Fatibene; A Lyon; S Monteith; A Parsons; S Haydock; R V Hopper; N G Stephens; K M O'Shaughnessy; M J Brown
Journal:  Circulation       Date:  1999-10-05       Impact factor: 29.690

Review 8.  Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases.

Authors:  Gustavo H Oliveira-Paula; Riccardo Lacchini; Jose E Tanus-Santos
Journal:  Nitric Oxide       Date:  2016-08-25       Impact factor: 4.427

9.  Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects.

Authors:  Juan P Casas; Leonelo E Bautista; Steve E Humphries; Aroon D Hingorani
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

10.  Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension.

Authors:  Azim Nejatizadeh; Rahul Kumar; Tsering Stobdan; A K Goyal; Sunandan Sikdar; Mohit Gupta; Saleem Javed; M A Qadar Pasha
Journal:  Free Radic Biol Med       Date:  2008-02-20       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.